Tamara Gennadievna Denisova

Tamara Gennadievna Denisova

Auto-generated profile, based on publicly available information

Tamara Gennadievna Denisova

Chuvash State University

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Russian Bulletin of Obstetrician-Gynecologist
Verified
Journal Article
Closed access
LML. I. Maltseva
L. I. Maltseva
EVE. N. Vasilyeva
E. N. Vasilyeva
TDT. G. Denisova
T. G. Denisova

1 January 2020 in Clinical Medicine Insights: Case Reports
Verified
Journal Article
Open access
PDF file
SMSeema Mahesh
Seema Mahesh
TDTamara Denisova
Tamara Denisova
LGLiudmila Gerasimova
Liudmila Gerasimova
NPNadezhda Pakhmutova
Nadezhda Pakhmutova
MMMahesh Mallappa
Mahesh Mallappa
GVGeorge Vithoulkas
George Vithoulkas
Classical homeopathy was shown to be beneficial in climacteric syndrome in many studies, but the clinical effect is unclear. To inspect if individualized classical homeopathy has a role in treating complaints after surgical menopause through real world case, we present a case of a 54-year-old Russian woman treated with individualized classical homeopathy for multimorbid conditions after surgical menopause examined for changes from homeopathic treatment. We assessed changes in climacteric symptoms, changes in comorbidities, and the general well-being of the patient. The woman had severe climacteric syndrome, pelvic inflammatory disease, dyslipidemia, obesity, hepatic steatosis, pancreatic lipomatosis, gall bladder disease, and mild subclinical hypothyroidism to begin with. She was treated with individualized classical homeopathy and followed up for 31 months. She was relieved of the vasomotor symptoms and psychological disturbances of climacteric syndrome, her weight reduced, the ultrasound scan showed absence of lipomatosis/gall bladder disease/hepatic steatosis. Blood tests showed reduction of thyroid stimulating hormone and a balance in the lipid status. Individualized classical homeopathy may have a role in the climacteric syndrome and comorbidities after surgical menopause. The efficacy of homeopathic therapy in climacteric problems must be scientifically investigated further.

30 September 2021 in Acta medica Eurasica
Verified
Journal Article
Closed access
TDTamara G. Denisova
Tamara G. Denisova
ASAdelina I. Sergeeva
Adelina I. Sergeeva
AGAlexandra S. Grigorieva
Alexandra S. Grigorieva
EREnje E. Rechapova
Enje E. Rechapova
ISIvan I. Sergeev
Ivan I. Sergeev
EDElena A. Denisova
Elena A. Denisova
According to the WHO statement dated March 11, 2020, the coronavirus infection SARS-CoV-2 has reached the scale of a pandemic and is currently a world health problem. A special group of the population that requires increased attention is pregnant women due to the fact that pneumonia occupies the third place in the structure of indirect causes of maternal mortality. Pregnant women whose immune system has changed appeared to be at an increased risk of infection. Pregnancy is a risk factor for the development of a more severe course of acute respiratory viral diseases and influenza. To date, the issue of intrauterine transmission of coronavirus disease remains completely unexplored, which causes fear among pregnant women for the future generation. Addition of a new coronavirus infection SARS-CoV-2 has a negative impact on pregnancy, childbirth and the postpartum period, the health of newborns, especially in patients with a burdened obstetric history. Pregnancy itself and childbirth do not affect the course of COVID-19, but the infection addition can complicate the course of gestation, causing respiratory distress syndrome, premature birth and spontaneous miscarriages, congenital pneumonia and antenatal death of newborns born from covid-positive mothers. The literature published from December 1, 2019 to July 30, 2021 was searched in several databases, including PubMed, Web of Science, Google Scholar and the WHO COVID-19 database, of which 52 articles were selected for detailed consideration. The relevant literature was searched to understand the issues of infection transmission to newborns from infected mothers and the clinical manifestations of the disease in the former. As a result, it was found that newborns can become infected with SARS-Cov-2 in close contact with infected patients or asymptomatic virus carriers. However, based on the data of modern literature, it is impossible to unequivocally answer the questions posed, more facts are needed to solve the problem. The practical significance of the work is that the results of the study should be used for further studying the consequences of COVID-19 for the health of newborn children.

4 July 2019 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Open access
PDF file
EVE. N. Vasilyeva
E. N. Vasilyeva
LML. I. Maltseva
L. I. Maltseva
TDT. G. Denisova
T. G. Denisova
LGL. I. Gerasimova
L. I. Gerasimova
Aim: to study the possibility of reducing the incidence of preeclampsia (PE) by giving vitamin D and calcium (Ca) to pregnant women with a high PE risk starting from the second trimester of pregnancy.Materials and methods. A total of 101 patients from the PE high risk group were examined on weeks 14–16 of pregnancy followed by treatment with vitamin D and Ca; then, the course of pregnancy and labor was analyzed. Serum 25-hydroxycholecalciferol, vitamin D binding protein, endothelin 1-38, and ionized Ca were determined using enzyme immunoassays.Results. In the examined women at high risk of PE, severe serum deficiency of vitamin D and Ca was detected. In patients treated with vitamin D and Ca, a two-fold decrease in the incidence of PE, a three-fold decrease in the incidence of intrauterine growth retardation syndrome, and a decrease in the number of urgent surgery-assisted deliveries were found.Conclusion. Therapy with vitamin D and Ca from the second trimester of pregnancy increases the availability of vitamin D, leads to a more favorable course of pregnancy, and prevents the development of severe forms and early onset of PE in patients at high risk.

15 October 2017 in Kazan medical journal
Verified
Journal Article
Open access
PDF file
EVE N Vasil’eva
E N Vasil’eva
LML I Mal’tseva
L I Mal’tseva
TDT G Denisova
T G Denisova
LGL I Gerasimova
L I Gerasimova
Aim. Evaluation of health state in newborns whose mothers were at risk of pre-eclampsia, depending on vitamin D level. Methods. Study materials included peripheral blood from pregnant women and umbilical cord blood of newborns. Vitamin D level was measured by enzyme-linked immunoassay kits of BIOMEDICAGRUPPE company (Germany). Intrauterine fetal state was studied with the use of ultrasonography. Results. Analysis of the study proved that vitamin D level in the umbilical cord blood correlates with its concentration in the mother’s blood. In women at pre-eclampsia risk decreased calcium level and vitamin D deficiency in the blood were detected. Administration of 2,000 IU of vitamin D and 1.5 g of calcium from the beginning of 2nd trimester of pregnancy resulted in reduction of frequency and severity of pre-eclampsia and its complications, including intrauterine growth retardation. Use of vitamin D in combination with calcium supplementation was shown to significantly improve unfavorable perinatal outcomes in women at high risk of pre-eclampsia, reducing by 3 times hypoxia and cerebral fetal lesions frequency that proves the vitamin D importance for functioning of mother-placenta-fetus system. Conclusion. Children of patients at risk of pre-eclampsia not taking vitamin D and calcium supplementation have lower birth weight and Apgar score, they have more frequent perinatal complications.

1 October 2018 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
MMMaltseva L.I. Maltseva
Maltseva L.I. Maltseva
VVVasilyeva E.N. Vasilyeva
Vasilyeva E.N. Vasilyeva
DDDenisova T.G. Denisova
Denisova T.G. Denisova